Medroxyprogesterone acetate

Medroxyprogesterone acetate is a type of progestin, a synthetic form of the hormone progesterone. It is used to treat a variety of conditions, including endometriosis, abnormal uterine bleeding, amenorrhea, and secondary amenorrhea. It is also used to prevent endometrial hyperplasia in postmenopausal women, and to reduce the risk of endometrial cancer. Medroxyprogesterone acetate is available in oral, intramuscular, and injectable forms. Side effects may include nausea, vomiting, headache, breast tenderness, and changes in menstrual bleeding.

While I cannot directly provide a full medical description of Medroxyprogesterone acetate (MPA), here's some general information:

Medroxyprogesterone acetate is a medication classified as a progestin.

  • Progestins are synthetic hormones similar to the female sex hormone, progesterone.

Medical purposes:

  • Birth control: MPA is a well-established and effective form of long-acting reversible contraception. It's commonly known under the brand name Depo-Provera, administered as an injection typically lasting 3 months.
  • Treatment:
    • Abnormal uterine bleeding: Helps regulate menstrual periods.
    • Endometriosis: Manages pain associated with the condition.
    • Certain hormone-responsive cancers: May be used in specific cases.

Important to know:

  • MPA is a prescription medication and should only be used under the supervision of a healthcare professional.
  • It requires a doctor's evaluation to determine suitability based on individual medical history.
  • Potential side effects exist, including irregular bleeding, weight changes, and mood swings. A doctor can discuss these in detail.

Disclaimer: This information is for general knowledge only and does not constitute medical advice. Consulting a licensed physician is vital for:

  • Understanding the complete picture of MPA, including potential benefits and risks.
  • Discussing if MPA is suitable for your specific needs and medical situation.
  • Exploring alternative treatment options if necessary.
Anatomical Therapeutic Chemical Classification
G - Genito-urinary system and sex hormones
G03 Sex hormones and modulators of the genital system
G03A - Hormonal contraceptives for systemic use
G03AC Progestogens
Anatomical Therapeutic Chemical Classification
G - Genito-urinary system and sex hormones
G03 Sex hormones and modulators of the genital system
G03D - Progestogens
G03DA Pregnen-(4) derivatives
Anatomical Therapeutic Chemical Classification
L - Antineoplastic and immunomodulating agents
L02 Endocrine therapy
L02A - Hormones and related agents
L02AB Progestogens
Anatomical Therapeutic Chemical Classification
G - Genito-urinary system and sex hormones
G03 Sex hormones and modulators of the genital system
G03A - Hormonal contraceptives for systemic use
G03AA Progestogens and estrogens, fixed combinations
External Links